[144] Parker-Hannifin Corporation SEC Filing
Filing: Parker-Hannifin Corporation (PH) Form 144 (LIVE) reporting a proposed sale under Rule 144.
Transaction details: 2,257 common shares to be sold through broker Kestra (address shown) on 08/08/2025 on the NYSE. Aggregate market value reported as $1,660,023.00 and shares outstanding listed as 128,410,000. The securities were acquired as a stock award on 04/24/2025; payment/consideration listed as compensation.
Other: The filer reports Nothing to Report for securities sold in the past three months. Remarks include the attestation about absence of undisclosed material adverse information and a signature notice.
- None.
- None.
Insights
TL;DR: Routine Rule 144 sale of 2,257 shares acquired as a stock award; disclosure is standard and appears procedural.
The filing discloses a proposed Rule 144 sale of 2,257 common shares via Kestra on 08/08/2025 with an aggregate market value of $1,660,023.00. Acquisition is documented as a 04/24/2025 stock award paid as compensation. The filer certifies no undisclosed material adverse information and reports no sales in the past three months. Impact for investors is likely neutral, as the filing is a routine insider disposition notice and contains no new operational or financial metrics.
TL;DR: Compliance-focused filing showing timely disclosure of an insider award sale; governance controls appear followed.
The Form 144 records required elements: issuer details, broker (Kestra) information, quantity (2,257) and timing (08/08/2025), acquisition date (04/24/2025), and payment type (compensation). The signer attests to absence of undisclosed material adverse information and notes no recent sales. From a governance perspective this reflects procedural compliance with Rule 144 disclosure obligations. No material governance concerns are identified within the filing text.